"Procainamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
Descriptor ID |
D011342
|
MeSH Number(s) |
D02.065.277.650 D02.241.223.100.050.500.875 D02.241.223.100.100.650 D02.455.426.559.389.127.020.937.875 D02.455.426.559.389.127.085.650
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Procainamide".
Below are MeSH descriptors whose meaning is more specific than "Procainamide".
This graph shows the total number of publications written about "Procainamide" by people in this website by year, and whether "Procainamide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Procainamide" by people in Profiles.
-
Huang Y, Wang LL, Liu ZB, Chen C, Ren X, Luo AT, Ma JH, Antzelevitch C, Barajas-Mart?nez H, Hu D. Underlying mechanism of atrial fibrillation-associated Nppa-I137T mutation and cardiac effect of potential drug therapy. Heart Rhythm. 2024 02; 21(2):184-196.
-
Samuels LE, Holmes EC, Samuels FL. Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation. Ann Thorac Surg. 2005 Jan; 79(1):113-6.
-
Fish JM, Antzelevitch C. Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm. 2004 Jul; 1(2):210-7.
-
Rials SJ, Britchkow D, Marinchak RA, Kowey PR. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia. Clin Cardiol. 2000 Mar; 23(3):171-4.
-
Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, Vanderlugt JT, Kowey PR. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol. 1998 May; 31(6):1414-9.
-
Haberman RJ, Rials SJ, Stohler JL, Marinchak RA, Kowey PR. Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugs. Am Heart J. 1993 Nov; 126(5):1121-6.
-
Kidwell GA, Greenspon AJ, Greenberg RM, Volosin KJ. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans. Circulation. 1993 Jan; 87(1):118-25.
-
Podrid PJ, Kowey PR, Frishman WH, Arnold RJ, Kaniecki DJ, Beck JR, Beshansky JR. Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine. Am J Cardiol. 1991 Dec 15; 68(17):1662-7.
-
Vlasses PH, Kosoglou T, Chase SL, Greenspon AJ, Lottes S, Andress E, Ferguson RK, Rocci ML. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide. Arch Intern Med. 1989 Jun; 149(6):1350-3.
-
Michelson EL, McGeehin FC, Levin BK. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias. Angiology. 1988 Jul; 39(7 Pt 2):647-54.